Microvesicles derived from mesenchymal stem cells: A promising therapeutic strategy for acute respiratory distress syndrome-related pulmonary fibrosis?

Pulmonary fibrosis significantly contributes to the pathogenesis of acute respiratory distress syndrome (ARDS), markedly increasing patient mortality. Despite the established anti-fibrotic effects of mesenchymal stem cells (MSCs), numerous

Microvesicles derived from mesenchymal stem cells: A promising therapeutic strategy for acute respiratory distress syndrome-related pulmonary fibrosis?

Pulmonary fibrosis significantly contributes to the pathogenesis of acute respiratory distress syndrome (ARDS), markedly increasing patient mortality. Despite the established anti-fibrotic effects of mesenchymal stem cells (MSCs), numerous

Espaço: Uma nova fronteira para explorar a terapia com células-tronco

As células-tronco cultivadas em microgravidade a bordo da Estação Espacial Internacional (EEI) possuem qualidades únicas que poderão, um dia, ajudar a potencializar as novas bioterapias e a curar doenças complexas, de acordo com dois pesquisadores da Mayo Clinic. A análise da pesquisa pelo pesquisador Fay Abdul Ghani e pelo Dr. e Ph.D. Abba Zubair, publicada na NPJ Microgravity, descobriu que a microgravidade pode fortalecer o potencial regenerativo das células. O Dr. Zubair é especialista em medicina laboratorial e diretor médico do Centro de Bioterapias Regenerativas na Mayo Clinic, na Flórida. Abdul Ghani é um tecnólogo em pesquisa da Mayo Clinic. A microgravidade é a ausência de peso ou gravidade próxima a zero.

Espacio: Una nueva frontera para explorar la terapia con células madre

Las células madre cultivadas en microgravedad a bordo de la Estación Espacial Internacional (EEI) poseen cualidades únicas que algún día podrán ayudar a potenciar las nuevas bioterapias y curar enfermedades complejas, según dos investigadores de Mayo Clinic. El análisis de la investigación por el investigador Fay Abdul Ghani y por el Dr. y Ph.D. Abba Zubair, publicado en NPJ Microgravity ha hallado que la microgravidad puede fortalecer el potencial regenerativo de las células. El Dr. Zubair es especialista en medicina de laboratorio y director médico del Centro de Bioterapias Regenerativas en Mayo Clinic, Florida. Abdul Ghani es tecnólogo de investigación en Mayo Clinic. La microgravedad es la ausencia o gravedad cercana a cero.

Enhancing the functionality of mesenchymal stem cells: An attractive treatment strategy for metabolic dysfunction-associated steatotic liver disease?

The intrinsic heterogeneity of metabolic dysfunction-associated fatty liver disease (MASLD) and the intricate pathogenesis have impeded the advancement and clinical implementation of therapeutic interventions, underscoring the critical dema

Pausing biological clock could boost lab-produced blood stem cells

An Iowa State University research team has discovered when and why inflammatory signaling affects the formation of blood stem cells in embryos, which will benefit efforts to develop lab-grown, patient-derived stem cell transfusions to treat blood disorders. The promising advancement in regenerative medicine could eliminate the need for bone marrow transplants.

Microvesicles derived from mesenchymal stem cells inhibit acute respiratory distress syndrome-related pulmonary fibrosis in mouse partly through hepatocyte growth factor

BACKGROUNDPulmonary fibrosis is one of the main reasons for the high mortality rate among acute respiratory distress syndrome (ARDS) patients. Mesenchymal stromal cell-derived microvesicles (MSC-MVs) have been shown to exert antifibrotic ef

Potential New Approach to Enhancing Stem-Cell Transplants

A discovery by a three-member Albert Einstein College of Medicine research team may boost the effectiveness of stem-cell transplants, commonly used for patients with cancer, blood disorders, or autoimmune diseases caused by defective stem cells, which produce all the body’s different blood cells.

Q&A: New Frontiers in ALS Research

Clive Svendsen, PhD, executive director of the Board of Governors Regenerative Medicine Institute and professor of Medicine and Biomedical Sciences at Cedars-Sinai, is developing new treatments and models for amyotrophic lateral sclerosis (ALS) using stem cells.

Study: Hillocks challenge our understanding of lung biology

A research team from Tufts University School of Medicine and Massachusetts General Hospital is now reporting evidence that hillocks and their stem cells are physiologically distinct from other cells within the lung and consist of a stratified outer layer of scale-like squamous cells that protect an underlying layer of rapidly expanding basal stem cells that are capable of restoring airway tissue after injury.